1
Home
Companies

Emyria

Emyria
Leadership team

Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D. (Exec. Chairman)

Dr. Michael Winlo (MD & Director)

Dr. Alistair Vickery (Exec. Medical Director & Director)

Products/ Services
Pharmaceuticals
Number of Employees
0 - 50
Headquarters
Perth, Western Australia, Australia
Established
2018
Company Registration
SEC CIK number: 0001227862
Revenue
500K - 2M
Traded as
ASX:EMD
Social Media
URL
https://emyria.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.
History

Emyria was founded in 2005 with a vision to provide powerful and scalable healthcare software to enable organizations to improve health outcomes, reduce costs, and improve communication across the care continuum.

Mission
To provide innovative and integrated clinical information systems that enable better patient care, health outcomes, and cost-effectiveness.
Vision
To be the leading provider of clinical and operational technologies to improve the lives of both individuals and medical professionals.
Key Team

Dr. Karen L. Smith L.L.M, L.L.M., M.B.A., M.D., PH.D. (Exec. Director & Chairman of Strategic Advisory Board)

Mr. Joseph Daniel Ohayon ACA, MBA Intl Bus. (Chief Financial Officer)

Ms. Tracie Ernenwein (Head of Research & Drug Devel.)

Mary-Ann Rennie (Head of Corp. Operations)

Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA (Company Sec.)

Recognition and Awards
Emyria has been recognized for excellence in healthcare IT solutions, and has been awarded numerous accolades including the 2016 HIMSS Davies Award for Improving Patient Outcome & Business Performance.
References

https://in.investing.com/equities/emerald-clinics-ltd

https://finance.yahoo.com/quote/EMD.AX/profile?p=EMD.AX

https://www.crunchbase.com/organization/emyria

https://emyria.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Emyria
Leadership team

Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D. (Exec. Chairman)

Dr. Michael Winlo (MD & Director)

Dr. Alistair Vickery (Exec. Medical Director & Director)

Products/ Services
Pharmaceuticals
Number of Employees
0 - 50
Headquarters
Perth, Western Australia, Australia
Established
2018
Company Registration
SEC CIK number: 0001227862
Revenue
500K - 2M
Traded as
ASX:EMD
Social Media
URL
https://emyria.com